India’s Biggest Hospital Chain IPO: Manipal Health Enterprises Price Band, Dates & GMP Explained

Spread love

By S. JHA

Manipal Health Enterprises IPO; Price Band, GMP, Lot Size and Everything Investors Need to Know

Mumbai, July 29, 2026 — Manipal Health Enterprises Limited, one of India’s largest hospital networks, has hit the primary market with one of the biggest IPOs of the year in the healthcare space.

Key Dates and Issue Details

The IPO will be available for subscription from Wednesday, July 29, 2026, to Friday, July 31, 2026, with anchor investor bidding scheduled for Tuesday, July 28, 2026. The basis of allotment is expected to be finalised on August 3, 2026, and the shares are tentatively scheduled to list on both the NSE and BSE on August 5, 2026.

The ₹9,273.64 crore IPO comprises a fresh issue of up to ₹7,998.43 crore and an Offer for Sale (OFS) of up to ₹1,275.22 crore by existing shareholders. The price band has been fixed between ₹560 and ₹590 per share, with a lot size of 25 shares, making the minimum investment for retail investors ₹14,750 at the upper end of the band.

Grey Market Signal

Ahead of the opening, unlisted market activity is offering an early read on demand. The Manipal Health Enterprises IPO GMP as of July 28, 2026 stands at ₹13, indicating an estimated listing premium of about 2.20% over the upper price band — a modest but positive signal heading into subscription day. GMP is an informal, unregulated indicator and tends to move quickly through the bidding window, so investors should treat it as a sentiment gauge rather than a firm listing forecast.

About the Business

Manipal Health Enterprises operates one of India’s largest pan-India multispecialty hospital networks, with 49 hospitals and 13,037 licensed beds across 14 states and union territories as of March 31, 2026. The company is part of the Manipal Group, one of India’s oldest names in private healthcare and education.

It ranks as the largest private hospital chain in India by bed capacity, and the second largest by number of hospitals.

Financial Snapshot

The company’s recent numbers show strong top-line growth but pressure on profitability. Revenue grew 26% in FY26, though profit after tax declined 15% over the same period. On an absolute basis, the company reported revenue of ₹10,520.52 crore in FY26 against ₹8,362.79 crore in FY25.

Where the Money Is Going

The company intends to use the fresh issue proceeds primarily for repayment or prepayment of outstanding borrowings and accrued interest at its material subsidiary, Manipal Hospitals Private Limited, along with acquiring a minority stake in step-down subsidiary Sahyadri Hospitals Private Limited, and general corporate purposes.

Ownership Structure Post-IPO

Promoters currently hold 81.43% of the company, a stake expected to fall to 72.08% after the IPO concludes.

Lead Managers and Registrar: The book running lead managers for the issue are Kotak Mahindra Capital Company, Axis Capital, Goldman Sachs (India) Securities, Jefferies India, J.P. Morgan India, UBS Securities India and DBS Bank India. Kfin Technologies Ltd. is the registrar for the issue.

Healthcare and Insurance Penetration

The IPO lands at a time when India’s hospital sector continues to attract heavy investor interest on the back of rising healthcare demand, insurance penetration and expansion into tier-2 cities. As one of the largest listings of the year, the Manipal Health Enterprises offering will be closely watched as a bellwether for appetite in the healthcare and hospital-chain space on Dalal Street.

(Disclosure: This is an informational overview of the IPO and should not be construed as investment advice. Investors are advised to read the Red Herring Prospectus carefully and consult a registered financial advisor before subscribing.)